We describe conditions for unmasking virus-specific protein synthesis in cells infected with rhinoviruses 1A and 2. The gene order and cleavage pattern of rhinovirus 1A show many similarities to those of encephalomyocarditis virus and of poliovirus.
The rhinoviruses resemble other picornaviruses, including poliovirus and encephalomyocarditis (EMC) virus, in size and composition (5); they are distinguished, however, from the other picornaviruses by their high buoyant density in cesium chloride solution and by their acid lability. Thus the taxonomic relationship of rhinoviruses to other picornaviruses is still unclear. We show here that at least one rhinovirus (rhinovirus 1A) resembles poliovirus and EMC virus not only in size and composition, but also in location and order of capsid genes and probably several noncapsid genes as well.
Evidence that rhinoviruses 1A and 2, like poliovirus and EMC virus, are able to redirect protein synthesis from that of the host cell to that of the virus is presented in Fig. 1 . The electrophoretic profiles of proteins synthesized in HeLa cells 4 to 4.5 hr after infection with human rhinovirus 1A (hrv-1A) (Fig. 1A) or with human rhinovirus 2 (hrv-2) (Fig. iB) are reminiscent of that observed in EMC virus-infected cells (Fig. 1C , see also reference 1). We interpret the peaks in these profiles, which show characteristic differences as well as similarities, to represent polypeptides encoded by the respective viral genomes. In support of this interpretation, a profile similar to that shown in Fig. 1A was observed 3 hr postinfection with rhinovirus 1A; at 2 hr, however, the profile still resembled that of uninfected (control) cells.
To facilitate comparison of peaks in these profiles, lysates from HeLa cells infected with each of the rhinoviruses were subjected to coelectrophoresis with a lysate from "4C-labeled EMC virus-infected HeLa cells (panel C). Each rhinoviral peak is identified by its apparent molecular weight (x 10-3), relative to the reported (1) sizes of the EMC-encoded chains identified in panel C.
The capsid chains (a, f, y, 6, e) of hrv-1A (Fig. 1A ) and of hrv-2 ( Fig. 1B) were identified in separate co-electrophoresis experiments with the corresponding, purified 'IC-labeled virions (3) . Although the # and 6 chains, which are assumed to be cleavage products of the e chain (3), were not evident after a 30-min pulse, they did appear after longer labeling periods. The large hrv-1A chains, 92, 84, and 76, which are similar in size to EMC chains B, C, and D, behaved in pulse-chase experiments (to be reported later in detail) like precursors; little label was ever observed in the minor hrv-1A peak 101 which co-migrates with the EMC chain A. The same pulse-chase experiments showed that chains 39, 38, 35, 30, 25, and 8 were derived from larger precursors, whereas chains 55 and 47 were both primary stable products. The small amount of label in peaks 14 and 13, which could be resolved under other conditions into at least three peaks, precluded reliable interpretation of their kinetic behavior. Peaks 129 and 120 were not reproducibly observed.
To further characterize peaks in this profile we have examined the effect of the drug pactamycin on their synthesis. This drug has been used previously to establish the gene orders of poliovirus and of EMC virus (2, 4, 7, 8) . The method is based upon (i) the hypothesis that the picornaviral genome contains only one ribosomal initiation site, and (ii) the observation that, under suitable conditions, pactamycin interferes specifically with initiation of protein synthesis without preventing transation (6) . A pactamycin concentration is chosen which gives complete and rapid, but not immediate, cessation of incorporation of labeled amino acids into the culture to be studied. Thirty minutes later, whole cell lysates were prepared (1). For electrophoresis, samples were mixed with similarly prepared "4C-labeled EMC-infected HeLa cell lysate. Electrophoresis (from left to right) was on 10%o polyacrylamide gels (0.6 x 25 cm) containing 0.1% sodium dodecyl sulfate at 8 ma per gel for 17.5 hr, when the bromophenol blue (dye) marker had moved about 20 cm. Buffer and gel compositions and fractionation and determination of radioactivity in the gels were as previously described (3) . The (4, 7, 8) .
A similar pattern emerges from the pactamycin map of hrv-1A (Fig. 2) . Thus, the rhinoviral capsid chains (6, (5), we regard the existence of an apparent difference in size and number of noncapsid hrv-1A homologues as tentative pending further investigation.
While a number of differences are evident in the apparent size of some of the homologous capsid and noncapsid chains, we wish to emphasize here the basic similarities with EMC Fig. 1 Fig. 2A (19-min pulse, 104-min chase) . The percent of total recovered radioactivity was calculated for each peak on a gel. The ratio of this percentage in the pactamycin-treated lysate to that of the corresponding peak in the control lysate (the pactamycin to control ratio) was calculated for each component as described previously (2 ment shown in Fig. 2A , they were resolved (with the loss of 8) by a longer electrophoresis period. The positions of components indicated by small numerals represent ratios calculated from peaks containing less than 5% of the total recovered label; the reliability of these values is uncertain. C, Pactamycin map of early gene products from rhinovirus IA (6-min delay, 8-min pulse). At 4 hr postinfection, pactamycin was added (to 10-7 M) to 2 ml of the infected culture. 31-amino acid mixture (to 100 uCi/ml) was added 6 min after pactamycin, and incorporation was terminated 8 min later. Another 2-ml sample was pulsed with 3H-amino acids for 8 min, beginning at 4 hr and 6 min postinfection. Both samples were disrupted, dialyzed, and subjected to electrophoresis as described previously (2) . Pactamycin to control ratios were calculated as described above; the values reported are averages from two experi- 
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